A detailed history of Charles Schwab Investment Management Inc transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 206,480 shares of MEDP stock, worth $68.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
206,480
Previous 202,234 2.1%
Holding current value
$68.4 Million
Previous $81.7 Million 4.04%
% of portfolio
0.02%
Previous 0.02%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$372.0 - $424.34 $1.58 Million - $1.8 Million
4,246 Added 2.1%
206,480 $85 Million
Q1 2024

May 08, 2024

SELL
$284.87 - $413.31 $2.84 Million - $4.13 Million
-9,981 Reduced 4.7%
202,234 $81.7 Million
Q4 2023

Feb 06, 2024

SELL
$227.52 - $312.68 $172,460 - $237,011
-758 Reduced 0.36%
212,215 $65.1 Million
Q3 2023

Nov 08, 2023

SELL
$233.98 - $281.67 $2.76 Million - $3.33 Million
-11,817 Reduced 5.26%
212,973 $51.6 Million
Q2 2023

Aug 09, 2023

SELL
$187.26 - $240.17 $8.03 Million - $10.3 Million
-42,871 Reduced 16.02%
224,790 $54 Million
Q1 2023

May 11, 2023

BUY
$174.31 - $239.52 $99,182 - $136,286
569 Added 0.21%
267,661 $50.3 Million
Q4 2022

Feb 13, 2023

SELL
$153.06 - $226.57 $1.68 Million - $2.48 Million
-10,949 Reduced 3.94%
267,092 $56.7 Million
Q3 2022

Nov 14, 2022

SELL
$145.13 - $182.49 $444,097 - $558,419
-3,060 Reduced 1.09%
278,041 $43.7 Million
Q2 2022

Aug 15, 2022

SELL
$130.2 - $168.03 $603,086 - $778,314
-4,632 Reduced 1.62%
281,101 $42.1 Million
Q1 2022

May 13, 2022

SELL
$138.87 - $214.31 $152,757 - $235,741
-1,100 Reduced 0.38%
285,733 $46.7 Million
Q4 2021

Feb 11, 2022

BUY
$182.74 - $227.9 $1.56 Million - $1.95 Million
8,542 Added 3.07%
286,833 $62.4 Million
Q3 2021

Nov 16, 2021

BUY
$170.18 - $198.21 $2.89 Million - $3.36 Million
16,953 Added 6.49%
278,291 $52.7 Million
Q2 2021

Aug 16, 2021

BUY
$158.62 - $194.3 $1.11 Million - $1.36 Million
6,991 Added 2.75%
261,338 $46.2 Million
Q1 2021

May 17, 2021

BUY
$132.02 - $168.26 $2.1 Million - $2.68 Million
15,905 Added 6.67%
254,347 $41.7 Million
Q4 2020

Feb 16, 2021

SELL
$109.38 - $149.19 $9.01 Million - $12.3 Million
-82,388 Reduced 25.68%
238,442 $33.2 Million
Q3 2020

Nov 13, 2020

SELL
$92.95 - $130.61 $1.3 Million - $1.83 Million
-13,997 Reduced 4.18%
320,830 $35.9 Million
Q2 2020

Aug 14, 2020

BUY
$68.08 - $95.68 $5.5 Million - $7.73 Million
80,819 Added 31.82%
334,827 $31.1 Million
Q1 2020

May 15, 2020

BUY
$61.71 - $101.95 $1.16 Million - $1.92 Million
18,823 Added 8.0%
254,008 $18.6 Million
Q4 2019

Feb 07, 2020

BUY
$70.08 - $84.64 $440,803 - $532,385
6,290 Added 2.75%
235,185 $19.8 Million
Q3 2019

Nov 08, 2019

SELL
$62.38 - $85.89 $848,555 - $1.17 Million
-13,603 Reduced 5.61%
228,895 $19.2 Million
Q2 2019

Aug 09, 2019

BUY
$53.64 - $65.42 $2.67 Million - $3.25 Million
49,731 Added 25.8%
242,498 $15.9 Million
Q1 2019

May 14, 2019

BUY
$49.38 - $70.58 $259,096 - $370,333
5,247 Added 2.8%
192,767 $11.4 Million
Q4 2018

Feb 14, 2019

SELL
$46.97 - $63.98 $662,558 - $902,501
-14,106 Reduced 7.0%
187,520 $9.93 Million
Q3 2018

Nov 13, 2018

BUY
$43.25 - $63.74 $4.97 Million - $7.32 Million
114,910 Added 132.51%
201,626 $12.1 Million
Q2 2018

Aug 08, 2018

BUY
$34.03 - $45.46 $460,017 - $614,528
13,518 Added 18.47%
86,716 $3.73 Million
Q1 2018

May 07, 2018

BUY
$32.03 - $39.05 $484,677 - $590,904
15,132 Added 26.06%
73,198 $2.56 Million
Q4 2017

Jan 17, 2018

BUY
$32.46 - $38.31 $927,739 - $1.09 Million
28,581 Added 96.93%
58,066 $2.11 Million
Q3 2017

Nov 13, 2017

BUY
$27.43 - $33.11 $808,773 - $976,248
29,485
29,485 $941,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.3B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.